ABILIFY (aripiprazole) Tablets, 30 mg recall — FDA D-181-2013
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and…
Overview of recall records associated with Bristol Myers Squibb Manufacturing Company, including dates, categories and classifications where available.
Classification mix: Class II: 1.
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and…
This page summarizes recall records in which the official source identifies Bristol Myers Squibb Manufacturing Company as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.